Valiant Laboratories Share Price
123.33-2.51 (-1.99%)
+47.31% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
LAURUSLABSNSE
ZYDUSLIFENSE
DRREDDYNSE
CIPLANSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
VALIANTLAB-BENSE
Valiant Laboratories Share Price
123.33-2.51 (-1.99%)
+47.31% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | - | -11% | 78% |
| - | - | - | -48% |
| - | - | -12% | 47% |
| 7% | 7% | -1% | -1% |
Peer Comparison
Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
LAURUSLABS
ZYDUSLIFE
DRREDDY
CIPLA
MANKIND
AUROPHARMA
LUPIN
VALIANTLAB-BE
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 1,769.9 | ₹424202 Cr | 38.68 | 8.29 | 58.23 | ₹11479 Cr |
| 10,064 | ₹264141 Cr | 90.3 | 34.04 | 128.41 | ₹2568 Cr |
| 4,650 | ₹174402 Cr | 82.11 | 14.04 | 106.21 | ₹2163 Cr |
| 2,323 | ₹126811 Cr | 94.64 | 8.17 | 33.94 | ₹889 Cr |
| 1,240.6 | ₹123685 Cr | 27.41 | 9.42 | 62.53 | ₹5040 Cr |
| 1,368.3 | ₹111868 Cr | 39.95 | 11.08 | 59.2 | ₹4196 Cr |
| 1,396.9 | ₹111650 Cr | 38.54 | 10.86 | 52.6 | ₹3879 Cr |
| 2,475 | ₹102196 Cr | 45.57 | 17.23 | 76.26 | ₹1913 Cr |
| 1,694.5 | ₹96951 Cr | 26.11 | 17.95 | 96.84 | ₹3505 Cr |
| 2,015.9 | ₹91301 Cr | 16.51 | 30.95 | 154.35 | ₹5333 Cr |
| 123.33 | ₹684 Cr | 42.76 | 3.89 | 4.49 | -₹3 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹117 Cr | ₹115 Cr | ₹92 Cr | ₹52 Cr | ₹46 Cr | ₹47 Cr | ₹58 Cr | ₹35 Cr | ₹21 Cr | ₹19 Cr | ₹31 Cr | ₹41 Cr | ₹60 Cr | ₹51 Cr | ₹90 Cr | ₹71 Cr | ₹88 Cr |
| ₹11 L | ₹86 L | ₹17 L | ₹63 L | ₹87 L | ₹66 L | -₹2 Cr | ₹2 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹78 L | ₹1 Cr |
| ₹117 Cr | ₹116 Cr | ₹92 Cr | ₹53 Cr | ₹47 Cr | ₹47 Cr | ₹55 Cr | ₹37 Cr | ₹25 Cr | ₹22 Cr | ₹33 Cr | ₹42 Cr | ₹63 Cr | ₹54 Cr | ₹92 Cr | ₹72 Cr | ₹89 Cr |
| ₹115 Cr | ₹89 Cr | ₹90 Cr | ₹55 Cr | ₹47 Cr | ₹45 Cr | ₹54 Cr | ₹35 Cr | ₹29 Cr | ₹22 Cr | ₹36 Cr | ₹47 Cr | ₹61 Cr | ₹48 Cr | ₹82 Cr | ₹61 Cr | ₹78 Cr |
| ₹5 Cr | ₹30 Cr | ₹5 Cr | -₹26 L | ₹95 L | ₹3 Cr | ₹2 Cr | ₹2 Cr | -₹3 Cr | ₹43 L | -₹2 Cr | -₹5 Cr | ₹2 Cr | ₹6 Cr | ₹10 Cr | ₹11 Cr | ₹12 Cr |
| ₹96 L | ₹1 Cr | ₹1 Cr | ₹68 L | ₹14 L | ₹7 L | ₹6 L | ₹6 L | ₹60,000 | ₹5 L | ₹2 L | ₹2 L | ₹2 L | ₹2 L | ₹3 L | ₹4 L | ₹17 L |
| ₹67 L | ₹26 Cr | ₹1 Cr | -₹3 Cr | ₹28 L | ₹2 Cr | ₹94 L | ₹2 Cr | -₹4 Cr | -₹16 L | -₹3 Cr | -₹5 Cr | ₹1 Cr | ₹6 Cr | ₹10 Cr | ₹10 Cr | ₹12 Cr |
| ₹42 L | ₹21 Cr | ₹2 Cr | -₹7 Cr | ₹20 L | ₹2 Cr | ₹70 L | ₹2 Cr | -₹5 Cr | -₹51 L | -₹1 Cr | -₹4 Cr | ₹79 L | ₹4 Cr | ₹8 Cr | ₹8 Cr | ₹9 Cr |
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| — | — | — | — |
| ₹54 Cr | ₹43 Cr | ₹43 Cr | ₹33 Cr |
| ₹257 Cr | ₹191 Cr | ₹193 Cr | ₹68 Cr |
| ₹257 Cr | ₹191 Cr | ₹193 Cr | ₹68 Cr |
| ₹311 Cr | ₹234 Cr | ₹237 Cr | ₹100 Cr |
| ₹28 Cr | ₹45 Cr | ₹15 Cr | ₹0 |
| ₹0 | ₹59 Cr | ₹59 Cr | ₹59 Cr |
| ₹4 Cr | ₹1 Cr | ₹62 L | ₹67 L |
| ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr |
| ₹15 L | ₹13 L | ₹8 L | ₹8 L |
| ₹34 Cr | ₹107 Cr | ₹77 Cr | ₹62 Cr |
| — | — | — | — |
| ₹94 Cr | ₹41 Cr | ₹26 Cr | ₹47 Cr |
| ₹8 Cr | ₹2 Cr | ₹2 Cr | ₹3 Cr |
| ₹17 Cr | ₹17 Cr | ₹1 Cr | ₹0 |
| ₹32 L | ₹20 L | ₹12 L | ₹12 L |
| ₹119 Cr | ₹60 Cr | ₹29 Cr | ₹51 Cr |
| ₹464 Cr | ₹401 Cr | ₹343 Cr | ₹213 Cr |
| ₹49 Cr | ₹62 Cr | ₹3 L | ₹3 L |
| ₹45 Cr | ₹121 Cr | ₹76 Cr | ₹59 Cr |
| — | — | — | — |
| ₹255 Cr | ₹71 Cr | ₹70 Cr | ₹66 Cr |
| ₹28 Cr | ₹22 Cr | ₹20 Cr | ₹18 Cr |
| ₹227 Cr | ₹48 Cr | ₹50 Cr | ₹48 Cr |
| ₹6 Cr | ₹156 Cr | ₹43 Cr | ₹68 L |
| ₹2 Cr | ₹4 Cr | ₹24 Cr | ₹14 Cr |
| ₹3 L | ₹0 | ₹0 | ₹0 |
| ₹236 Cr | ₹208 Cr | ₹117 Cr | ₹62 Cr |
| — | — | — | — |
| ₹26 Cr | ₹0 | ₹38 Cr | ₹34 Cr |
| ₹45 Cr | ₹4 Cr | ₹10 Cr | ₹13 Cr |
| ₹94 Cr | ₹72 Cr | ₹46 Cr | ₹89 Cr |
| ₹7 Cr | ₹76 Cr | ₹106 Cr | ₹1 Cr |
| ₹5 Cr | ₹81 L | ₹2 Cr | ₹1 Cr |
| ₹51 Cr | ₹40 Cr | ₹24 Cr | ₹12 Cr |
| ₹228 Cr | ₹193 Cr | ₹226 Cr | ₹151 Cr |
| ₹109 Cr | ₹133 Cr | ₹196 Cr | ₹100 Cr |
| ₹464 Cr | ₹401 Cr | ₹343 Cr | ₹213 Cr |
| ₹57 | ₹54 | ₹55 | ₹31 |
| ₹57 | ₹50 | ₹51 | ₹31 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| ₹77 L | -₹2 Cr | -₹77 L | ₹38 Cr |
| ₹7 Cr | ₹4 Cr | ₹2 Cr | ₹2 Cr |
| -₹17 Cr | -₹4 Cr | -₹37 L | ₹25 Cr |
| -₹9 Cr | -₹1 Cr | ₹90 L | ₹65 Cr |
| -₹10 Cr | ₹1 Cr | ₹2 Cr | ₹56 Cr |
| ₹7 Cr | -₹53 Cr | -₹144 Cr | -₹55 Cr |
| ₹2 Cr | ₹45 Cr | ₹152 Cr | -₹93 L |
| -₹1 Cr | -₹7 Cr | ₹10 Cr | -₹5 L |
| ₹5 Cr | ₹12 Cr | ₹1 Cr | ₹1 Cr |
| ₹4 Cr | ₹5 Cr | ₹12 Cr | ₹1 Cr |
Fundamental Ratios
Consolidated
Standalone
No results found
Valiant Laboratories Share Price
123.33-2.51 (-1.99%)
+47.31% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 3
Bearish signals: 1 out of 9 oscillators
RSI
49.16Neutral
STOCH %K
22.80Neutral
MACD Level(12,26)
2.34Buy
Ultimate Oscillator
46.83Sell
Aroon Oscillator
80.00Buy
BOP
0.00Neutral
CCI
-44.31Neutral
Williams %R
-77.20Neutral
Momentum
1.26Buy
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 4
Bearish signals: 5 out of 9 moving averages
EMA 9
126.52Sell
SMA 9
126.71Sell
EMA 21
125.50Sell
SMA 21
126.20Sell
EMA 50
116.08Buy
SMA 50
119.03Buy
EMA 200
90.90Buy
SMA 200
79.09Buy
WMA 20
127.23Sell
Pivot
Pivot
Classic
Resistance 5
137.80
Resistance 4
135.04
Resistance 3
132.28
Resistance 2
129.52
Resistance 1
127.68
Pivot
126.76
Support 1
124.92
Support 2
124.00
Support 3
121.24
Support 4
118.48
Support 5
115.72
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Valiant Laboratories Share Price
123.33-2.51 (-1.99%)
+47.31% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| 74.94% | 74.94% | 74.94% | 74.94% | 74.94% | 74.94% |
| 0.07% | 0.00% | 0.20% | 0.01% | 0.02% | 0.63% |
| 0.08% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 24.91% | 25.06% | 24.86% | 25.05% | 25.04% | 24.43% |
Bulk & block deals
Name
Metasoni Alloys Pvt Ltd
Metasoni Alloys Pvt Ltd
Trade Corner
Necta Bloom Vcc - Necta Bloom One
Marwadi Chandarana Intermediaries Brokers Private Limited
Money Logix Securities Pvt Ltd
Jainam Broking Limited
Jainam Broking Limited
Jaliyan Commodity
Jainam Broking Limited
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 17 Dec 2025 | Purchase | 2.10 Cr | ₹67.33 | 3.12 L | Bulk | 0.574452 | NSE |
| 17 Dec 2025 | Sell | 5.19 L | ₹66.98 | 7.74 K | Bulk | 0.014255 | NSE |
| 13 Jun 2025 | Sell | 2.83 Cr | ₹120.29 | 2.35 L | Bulk | 0.433049 | NSE |
| 31 Jan 2025 | Purchase | 2.83 Cr | ₹102.75 | 2.75 L | Bulk | 0.506329 | NSE |
| 31 Jan 2025 | Sell | 2.83 Cr | ₹102.75 | 2.75 L | Bulk | 0.506329 | NSE |
| 24 Jan 2025 | Purchase | 5.82 Cr | ₹105.78 | 5.50 L | Bulk | 1.012658 | NSE |
| 24 Jan 2025 | Sell | 5.82 Cr | ₹105.77 | 5.50 L | Bulk | 1.012658 | NSE |
| 07 Jun 2024 | Sell | 4.92 Cr | ₹142.80 | 3.44 L | Bulk | 0.634071 | NSE |
| 07 Jun 2024 | Purchase | 4.99 Cr | ₹142.81 | 3.49 L | Bulk | 0.642841 | NSE |
| 07 Jun 2024 | Purchase | 18.27 L | ₹148.54 | 12.30 K | Bulk | 0.022647 | NSE |
Insider trading & SAST
Client name
Valiant Organics Ltd
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10 Jun 2026 | Promoter | Acquisition | 34.26 | — | 0 | — | 1.86 Cr | 01 Jan 1900 | — | — | SAST | 10(5) | — |
Valiant Laboratories Share Price
123.33-2.51 (-1.99%)
+47.31% past 1 Year
Valiant Laboratories Limited is an Active Pharmaceutical Ingredient (API) / Bulk Drug manufacturing company having focus on manufacturing of Paracetamol. Bulk drugs/Active Pharmaceutical Ingredients (API) serve as raw materials for
Corporate Actions
Date
Type
Details
Company details
Valiant Laboratories Share Price
123.33-2.51 (-1.99%)
+47.31% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
No presentations found
Valiant Laboratories Share Price
123.33-2.51 (-1.99%)
+47.31% past 1 Year
News
Valiant Laboratories QC Manager Bhanudas D. Patil Resigns for Personal Reasons Effective April 22, 2026.
Equity
VALIANTLAB
Valiant Laboratories - Quaterly Results
Equity
VALIANTLAB
Valiant Laboratories reports Profit after tax of 3.30 Lakhs, in the December 2025 quarter
Equity
VALIANTLAB
Valiant Laboratories reports Profit after tax of 16.80 Lakhs, in the September 2025 quarter
Equity
VALIANTLAB
Valiant Laboratories informs about scrutinizers report
Equity
VALIANTLAB
Valiant Laboratories reports Profit after tax of 1.82 Crores, in the June 2025 quarter
Equity
VALIANTLAB
Valiant Laboratories - Quaterly Results
Equity
VALIANTLAB
Valiant Laboratories - Quaterly Results
Equity
VALIANTLAB
Valiant Laboratories - Quaterly Results
Equity
VALIANTLAB
Valiant Laboratories informs about credit rating
Equity
VALIANTLAB
Valiant Laboratories informs about credit ratings
Equity
VALIANTLAB
Valiant Laboratories - Quaterly Results
Equity
VALIANTLAB
Valiant Laboratories reports Profit after tax of 1.60 Crores, in the December 2024 quarter
Equity
VALIANTLAB
Valiant Laboratories - Quaterly Results
Equity
VALIANTLAB
Valiant Laboratories - Quaterly Results
Equity
VALIANTLAB
Valiant Laboratories informs about voting results of postal ballot
Equity
VALIANTLAB
Valiant Laboratories reports Profit after tax of Rs -5.98 Crores, in the September 2024 quarter
Equity
VALIANTLAB
Valiant Laboratories informs about credit rating
Equity
VALIANTLAB
Valiant Laboratories informs about newspaper publication
Equity
VALIANTLAB
Valiant Laboratories - Quaterly Results
Equity
VALIANTLAB